|
|
Volumn 15, Issue 2, 2014, Pages
|
|
Correction to Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: A randomised, open label, non-inferiority phase 3 trial [Lancet Oncol 15 (2014) 114-22]
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERRATUM;
ERROR;
PRIORITY JOURNAL;
|
|
EID: 84893003688
PISSN: 14702045
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(14)70048-8 Document Type: Erratum |
|
Times cited : (1)
|
|
References (0)
|